The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Crystal Amber plots more payouts; Orcadian fundraise

Fri, 01st Jul 2022 21:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Crystal Amber Fund Ltd - Guernsey-based investment company - Expects to return further 10 pence per share by mid-August and additional 60p per share by end of September. "If these distributions can be achieved, this would bring total returns in the first nine months of 2022 to 80p a share," Crystal Amber says.

----------

Orcadian Energy PLC - North Sea focused oil and gas development company - Raises GBP1 million through placing of 2.9 million shares at 35 pence each. Cash will go towards licence fees and for general working capital purposes.

----------

Ncondezi Energy Ltd - Mozambique-based power development company - Says restructuring talks in regard to working capital facility term loan with Seritza Ltd "progressing well" and to be finalised "imminently". "Whilst the principle terms are finalised Seritza has confirmed that it will extend the period in which it will not call in the loan to 8 July 2022," Ncondezi says.

----------

East Star Resources PLC - gold and copper exploration company focused on Kazakhstan - Says "multiple mineralised quartz veins" spotted from rock chip samples at Dalny licence on Chu-Ili gold belt in central Kazakhstan. "All quartz vein samples contained gold mineralisation," East Star says.

----------

Bradda Head Lithium Ltd - North America-focused lithium development company - Says results from initial scout drilling programme at Wikieup asset "demonstrate the presence of lithium bearing clays". Chief Executive Charles FitzRoy adds: "Further work is required, but these results are positive and will help in the planning our future programmes there." The project is located halfway between Phoenix and Las Vegas in US.

----------

Artemis Resources Ltd - Perth-based miner with gold, copper and cobalt projects in Australia - Says maiden drill programme planned at Osborne nickel sulphide target underway.

----------

Cornish Metals Inc - Vancouver-based mineral exploration company - Reports assay results from diamond drill holes designed to test Trenares Lode target at United Downs project in Cornwall, UK. Says "multiple zones of mineralisation" intersected at each drill section. Mineralisation is principally "tin - zinc - silver with minor copper".

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says company reserves up "materially" to 4.1 million ounces of gold from 1.1 million ounces reported in November. Resources up 8% to 7.3 million ounces of gold. Updates reserves and resources estimate includes maiden ore reserve at Kinkine deposit, higher-grade ore reserves at the Koekoe deposit and maiden reserves for Dugbe in Liberia.

----------

Open Orphan PLC - London-based pharmaceutical services - Says hVIVO unit is developing the world's first Omicron human challenge model. hVIVO signs deal with Nasdaq-listed Vaxart Inc to develop model to conduct Omicron human challenge study in 2023. Test will test efficacy of Vaxart's oral vaccine candidate, VXA-CoV2-1. "To develop the model, hVIVO will manufacture a new SARS-CoV-2 challenge agent based on the Omicron variant. The Good Manufacturing Practice compliant virus manufacturing activities will commence immediately and are expected to complete by Q4 2022," Open Orphan adds.

----------

Pharma C Investments PLC - New Jersey-based early-stage investor in the medical cannabis industry - Raises GBP200,000 through subscription of 80 million new shares at 0.25 pence each. "The proceeds of the subscription will be used to provide the company with additional working capital," Pharma C says.

----------

Schroder Real Estate Investment Trust Ltd - UK-focused real estate investment trust - Disposes of 26,975 square feet single let industrial asset in Portsmouth for GBP6.5 million. Sales price ops GBP4.9 million March 31 independent valuation. "Further disposals are under consideration, alongside potential acquisitions of adjoining ownerships where these support delivery of the asset business plan," company adds. Since March 31, completes 17 new letting, renewals and review, which will generate additional GBP2.7 million of annual rent and increase contracted rental income by GBP1.0 million per year.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Says realises investment in Roaring Fork Midstream at over 21% internal rate of return. In March of last year, Riverstone had committed USD5.9 million for first lien delayed-draw term loan to sponsor-backed Roaring Fork Midstream. Roaring Fork owns and operates pipeline and storage related infrastructure moving natural gas and oil from the wellhead to market.

----------

Mobile Streams PLC - London-based mobile content provider - Extends contract with International Gaming Systems for additional six months starting July. "The revenue share contract will see the two companies continue to undertake various joint projects in the areas of Esports, gaming and digital merchandise," Mobile Streams adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 11:45

Open Orphan's hVIVO wins GBP14.7 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said it's subsidiary hVIVO signed a GBP14.7 million contract for an influenza characterisation study and a follow on influenza human challenge study.

Read more
31 May 2022 16:05

UK earnings, trading statements calendar - next 7 days

Wednesday 1 June  
Impax Asset Management Group PLCHalf Year Results
Dr Martens PLCFull Year Results
Thursday 2 June  
no events scheduled 
Friday  3 June  
no events scheduled  
Monday 6 June  
Atrato Onsite Energy PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Jadestone Energy PLCFull Year Results
Tuesday 7 June  
Gooch & Housego PLCHalf Year Results
LXi REIT PLCFull Year Results
NewRiver REIT PLCFull Year Results
Open Orphan PLCFull Year Results
Schroder Real Estate Investment Trust LtdFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 16:43

Open Orphan's hVIVO wins GBP7.3 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said its subsidiary hVIVO Ltd has signed a GBP7.3 million contract.

Read more
18 May 2022 15:15

Open Orphan wins £7.3m human flu study contract

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.

Read more
6 May 2022 19:11

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 May 2022 14:53

IN BRIEF: Open Oprhan wins contract for vaccine field site study

Open Orphan PLC - London-based pharmaceutical services - Subsidiary hVIVO is awarded new study with existing unnamed pharmacetical client to act as vaccination site for the client's respiratory syncytial virus vaccine candidate. hVIVO's specialist arm FluCamp will recruit 60 healthy volunteers to the new site clinic at Plumbers Row where trials will take place.

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Apr 2022 20:23

IN BRIEF: Open Orphan Covid study results published in Nature Medicine

Open Orphan PLC - London-based pharmaceutical services - Says Thursday that results from the world's first Covid-19 characterisation study have been peer reviewed and published in the scientific journal Nature Medicine. Says study showed the SARS-CoV-2 human challenge was safe in healthy young adults and provided insights into the course of Covid-19 infection with potential positive public health implications. With the characterisation study disease modelling data completed, and human challenge model established, Open Orphan says it should be able to conduct Covid-19 human challenge studies in 2022.

Read more
25 Mar 2022 14:10

IN BRIEF: Open Orphan wins GBP5 million human challenge study pact

Open Orphan PLC - London-based pharmaceutical services firm - Says its subsidiary, hVIVO, wins contract with a European biotechnology company for a human challenge study. The GBP5 million contract with a European biotech seeks to test hVIVO's intravenous antiviral candidate. The study on the respiratory syncytial virus is expected to commence this year. Revenue from the deal will be recognised across 2022 and 2023.

Read more
25 Mar 2022 09:39

Open Orphan wins £5m contract for human study in RSV

(Sharecast News) - Open Orphan announced on Friday that its hVIVO subsidiary has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with an unnamed European biotechnology company, to test its intravenous antiviral candidate.

Read more
8 Mar 2022 19:37

IN BRIEF: Open Orphan expects to report profitable 2021 performance

Open Orphan PLC - London-based pharmaceutical services - For 2021, expects to report earnings before interest, tax, depreciation and amortisation, on revenue which is set to be GBP40 million, up from GBP20.6 million in 2020. For 2022, the company is targeting GBP50 million in non-Covid work revenue.

Read more
24 Feb 2022 15:24

Open Orphan appoints Mo Khan as its new chief executive

(Sharecast News) - Contract research organisation Open Orphan announced the appointment of Yamin 'Mo' Khan as its chief executive officer on Thursday, with immediate effect.

Read more
24 Feb 2022 14:48

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Feb 2022 20:13

IN BRIEF: Positive results from Open Orphan human challenge study

Open Orphan PLC - pharmaceutical services provider - Sees positive results from a human challenge study assessing its respiratory syncytial virus antiviral candidate, EDP-938. Says results from the study have been published in The New England Journal of Medicine. hVIVO, a subsidiary of Open Orphan, conducted the Phase 2a, double-blind, placebo-controlled trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.